EX-10.1
FibroBiologics, Inc.
SECURITIES PURCHASE AGREEMENT
THIS SECURITIES PURCHASE AGREEMENT(the “Agreement”), dated as of October 7, 2026, is entered into by and between FIBROBIOLOGICS, INC., a Delaware corporation, (the “Company”) and Peak One Opportunity Fund, L.P., a Delaware limited partnership (the “Buyer”).
WITNESSETH:
WHEREAS, the Company and the Buyer are executing and delivering this Agreement in accordance with and in reliance upon the exemption from securities registration afforded, inter alia, by Rule 506 under Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “1933 Act”), and/or Section 4(a)(2) of the 1933 Act; and
…